Fig. 6From: Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART studyMonthly variation of reports of flu-like syndrome and of related symptoms (headache, malaise, myalgias) (n = 62)Back to article page